Ticker: JAGX

Snapshot - JAGUAR HEALTH, INC. (NASDAQ: JAGX) Quick facts (as reported for quarter / six months ended June 30, 2025) * Total revenue: $2.979M (Q2); $5.193M (six months) - up modestly vs prior year (+9.5% Q2, +2.4% 6M). * Product revenue (Mytesi + animal products): $2.936M (Q2); $5.107M (6M). Lice...

Jaguar Health, Inc. (NASDAQ: JAGX) - Q1 2025 Financial Overview Jaguar Health, Inc. continues to navigate through significant challenges, marked by a strategic focus on expanding its product pipeline alongside ongoing financial difficulties. Here are the key points from the recent income statemen...